Axsome
is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read moreAxsome
is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read more
News
Apr 14, 2025
Benzinga
Axsome: SECURITIES FRAUD CLASS ACTIONS HAVE SURVIVED MOTIONS TO DISMISS: Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); and Virtu Financial Inc. (NASDAQ: VIRT) Should Contact Grabar Law Office Today
Apr 11, 2025
IndiaMedToday
Axsome: New Alzheimer's Therapy Brings Hope for Soothing Distress Without Antipsychotics
Apr 10, 2025
Benzinga
Axsome: Kuehn Law Encourages Investors of Axsome Therapeutics, Inc. to Contact Law Firm
Apr 08, 2025
GlobalNewswire
Press Release: Axsome : Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5
Apr 02, 2025
Zacks
Axsome: AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol
Apr 01, 2025
Seeking Alpha
Axsome: Axsome slips as late-stage trial for depression therapy fails
Apr 01, 2025
Investing.com
Axsome: Axsome shares fall after trial results disappoint By Investing.com
Apr 01, 2025
Bloomberg Law
Axsome: Axsome Must Face Securities Fraud Suit Over Migraine Drug Delays
Apr 01, 2025
Benzinga
Axsome: Axsome's Solriamfetol Fails Primary Goal In Depression Study But Shows Improvements In Associated Sleep Disorder
Mar 26, 2025
BioCentury
Axsome: Axsome's latest win comes in ADHD, Opthea seeks path after AMD miss, and more: Clinical Report
Axsome Competitors
1
2
3
4
5
6
7
8
9
10